Symbol | Marktkapitalisierung | Preis | Veränderung % | Volumen | Relatives Volumen | KGV | EPS-Verd. TTM | EPS-Verd. Wachstum TTM YoY | Dividendenrendite % TTM | Analysten-Rating |
---|---|---|---|---|---|---|---|---|---|---|
GRFGRIFOLS S.A. | 5.216 B EUR | 8.376 EUR | −3.26% | 2.338 M | 0.72 | 36.21 | 0.23 EUR | −71.83% | 0.00% | Kauf |
ROVILABORATORIOS FARMACEUTICOS ROVI S.A. | 4.292 B EUR | 79.60 EUR | −1.06% | 113.717 K | 2.16 | 24.72 | 3.22 EUR | −14.01% | 1.30% | Kauf |
ALMALMIRALL S.A. | 1.75 B EUR | 8.385 EUR | +0.30% | 111.551 K | 0.81 | — | −0.18 EUR | +23.28% | 1.78% | Kauf |
FAEFAES FARMA, S.A. | 1.025 B EUR | 3.275 EUR | −0.30% | 316.838 K | 1.68 | 11.07 | 0.30 EUR | +4.19% | 4.55% | Neutral |
PHMPHARMA MAR, S.A. | 505.266 M EUR | 28.42 EUR | +2.97% | 122.458 K | 3.57 | 513.00 | 0.06 EUR | — | 1.91% | Kauf |
RJFLABORATORIO REIG JOFRE, S.A. | 200.092 M EUR | 2.52 EUR | −0.40% | 2.788 K | 0.20 | — | — | — | 1.28% | — |
PRMPRIM, S.A. | 172.88 M EUR | 10.20 EUR | 0.00% | 2.215 K | 0.82 | — | — | — | 2.91% | — |
ORYORYZON GENOMICS, S.A. | 126.082 M EUR | 2.020 EUR | −0.49% | 114.762 K | 0.57 | — | −0.06 EUR | +24.94% | 0.00% | Starker Kauf |
NTHNATURHOUSE HEALTH, S.A | 98.017 M EUR | 1.670 EUR | +2.14% | 24.912 K | 0.87 | 8.86 | 0.19 EUR | +25.35% | 7.43% | — |
PANGPANGAEA ONCOLOGY S.A. | 54.188 M EUR | 1.71 EUR | −3.93% | 3.911 K | 0.02 | — | — | — | 0.00% | — |
BSTBIOTECHNOLOGY ASSETS, S.A. | 19.824 M EUR | 0.3575 EUR | +3.92% | 248.365 K | 2.19 | — | — | — | 0.00% | — |
VYTVYTRUS BIOTECH, S.A. | 17.219 M EUR | 2.42 EUR | 0.00% | 0 | 0.00 | — | — | — | 0.00% | Starker Kauf |
LABLABIANA HEALTH, S.A. | 11.915 M EUR | 1.65 EUR | 0.00% | 0 | 0.00 | — | — | — | 0.00% | — |